Description
DSIP Injectable Therapy – Delta Sleep-Inducing Peptide for Deep Sleep, Stress Recovery & Neuromodulation
Delta Sleep-Inducing Peptide (DSIP) is a synthetic analog of a neuropeptide first identified for its role in promoting sleep onset and maintaining deeper stages of non-REM sleep. It has since been studied for its potential to influence sleep regulation, stress adaptation, and hormonal balance.
Unlike traditional sedatives, DSIP does not cause sedation or disrupt natural sleep architecture. Instead, it may enhance sleep quality by supporting normal circadian rhythm signaling and reducing nighttime awakenings. It is often utilized in wellness, recovery, and stress-reduction protocols, especially among individuals with insomnia, burnout, or HPA axis dysregulation.
Key Benefits:
- Promotes deep, restorative sleep
- May reduce sleep onset latency and nighttime awakenings
- Supports adaptation to physical or emotional stress
- May help modulate cortisol and other stress-related hormones
- May improve mood, energy, and cognitive clarity as a result of improved sleep
Formulation & Administration:
- Form: Injectable (Subcutaneous)
- Frequency: Typically administered nightly or as directed by a provider
- Strength: Custom-compounded per provider instruction
DSIP may be used as a standalone therapy or in combination with other wellness peptides for sleep, recovery, and mental performance.
Clinical Considerations:
- Does not cause sedation or dependence
- Often well tolerated with minimal reported side effects
- May be considered for patients with insomnia, chronic fatigue, or adrenal dysregulation
Important Information & Disclaimer
This compounded medication has not been reviewed by the FDA for safety or efficacy. It is intended for use only under the supervision of a licensed medical provider. Individual results may vary. Not intended to diagnose, treat, cure, or prevent any disease.
